Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index; 19 of the 47 sources its claims cite were checked for support.

The δ subunit of F1Fo-ATP synthase is required for pathogenicity of Candida albicans

Open access
Li, Shuixiu, Zhao, Yajing, Zhang, Yishan, Zhang, Yanli, Zhang, Zhanpeng, Tang, Chuanyan, Weng, Luobei, Chen, Xiaohong, Zhang, Gehua, Zhang, Hong · 2021 · Nature Communications

Abstract

Fungal infections, especially candidiasis and aspergillosis, claim a high fatality rate. Fungal cell growth and function requires ATP, which is synthesized mainly through oxidative phosphorylation, with the key enzyme being F 1 F o-ATP synthase. Here, we show that deletion of the Candida albicans gene encoding the δ subunit of the F 1 F o-ATP synthase (ATP16) abrogates lethal infection in a mouse model of systemic candidiasis. The deletion does not substantially affect in vitro fungal growth or intracellular ATP concentrations, because the decrease in oxidative phosphorylation-derived ATP synthesis is compensated by enhanced glycolysis. However, the ATP16-deleted mutant displays decreased phosphofructokinase activity, leading to low fructose 1,6-bisphosphate levels, reduced activity of Ras1-dependent and -independent cAMP-PKA pathways, downregulation of virulence factors, and reduced pathogenicity. A structure-based virtual screening of small molecules leads to identification of a compound potentially targeting the δ subunit of fungal F 1 F o-ATP synthases. The compound induces in vitro phenotypes similar to those observed in the ATP16-deleted mutant, and protects mice from succumbing to invasive candidiasis. Our findings indicate that F 1 F o-ATP synthase δ subunit is required for C. albicans lethal infection and represents a potential therapeutic target.

Overview

CoChat Summary

TL;DR

Deletion of ATP16, encoding the δ subunit of Candida albicans F1Fo-ATP synthase, abrogates lethal systemic infection in mice despite preserving intracellular ATP through enhanced glycolysis. The virulence defect is linked to reduced Pfk1 activity/FBP and cAMP-PKA signaling, and a virtual-screening compound mimics the mutant phenotype and protects mice.

Key findings

  • atp16Δ/Δ-infected mice had 100% survival at 90 days versus 0% survival at 8 days for WT-infected mice, even when the atp16Δ/Δ challenge dose was increased 10-fold; fungal burdens became undetectable at 72 h, and complementation with ATP16 restored WT-like lethality.
  • Intracellular ATP was not perceptibly different from WT, but OXPHOS-derived ATP synthesis in atp16Δ/Δ was ~6% of WT, basal OCR was ~0 nmol O2/min/10^5 cells, glucose uptake was 4-fold higher, ECAR was 1.5-fold higher, and with 2-DG intracellular ATP fell ~84-fold.
  • atp16Δ/Δ showed impaired filamentation, adhesion, biofilm formation, and virulence-gene expression; intracellular FBP was 22-fold lower (4.5% of WT), Pfk1 activity was 9.1% of WT, PKA phosphorylation was reduced by 35%, and GTP-Ras1 activity was reduced by 81%. Exogenous FBP, cAMP, or IBMX restored filamentation.
  • Compound S1 (JNU-SM919, C26H29ClN4O2S), identified by structure-based virtual screening, inhibited WT growth in YPS and filamentation at 10 μM; S1-treated mice had a 60% survival rate 30 days after systemic WT infection, with reduced fungal burdens and kidney inflammation.

Methods

  • C. albicans SC5314 WT, atp16Δ/Δ, atp16Δ/ATP16 complemented, and Atp16 O/E strains were tested in female BALB/c mice (8–10 weeks old) by intravenous infection with 5 × 10^5 CFU (or 5 × 10^6 CFU for high-dose atp16Δ/Δ), followed by survival monitoring, organ CFU, histopathology, blood chemistry, and MicroPET/CT with [18F]FDG.
  • Mechanistic assays included targeted metabolomics, proteomics, luciferase/luciferin ATP measurement, Seahorse OCR/ECAR, ROS and ΔΨm assays, F1Fo-ATPase activity, RT-qPCR, macrophage co-culture, Pfk1 purification/phosphorylation, and enzyme activity assays.
  • Structure-based virtual screening used homology modeling from S. cerevisiae F1Fo-ATP synthase (PDB 6CP3) and docked >250,000 compounds; S1 was tested in vitro and in mice by oral gavage at 50 or 100 mg/kg once daily for 7 days. Statistics used t-tests, one-way or two-way ANOVA, and log-rank tests, with P < 0.05; proteomics/metabolomics used fold change >1.5.

Limitations

  • Stated in the paper: the mechanisms by which δ subunit deletion induces reduced Pfk1 phosphorylation and activity remain unknown; S1 provides only indirect evidence that it may act on the δ subunit; and the structure of F1Fo-ATP synthase from human pathogenic fungi has not been elucidated, so the receptor was homology-modeled from S. cerevisiae.
  • Evident from the text: all infection and S1 efficacy data are from mouse models, with no human clinical validation; direct target engagement of S1 with the C. albicans δ subunit was not demonstrated; and the paper reports no explicit limitations section beyond the caveats noted above.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-021-26313-9

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 A mutant C. albicans strain carrying a deletion of the δ subunit fails to cause lethal infection. a Survival curves of mice (n = 10) after intravenous injection with NS and infection with C. albicans WT (5 × 105 colony-forming units (CFU) per mice), atp16Δ/Δ (5 × 105 CFU per mice), atp16Δ/ATP16 (5 × 105 CFU per mice), and atp16Δ/Δ (5 × 106 CFU per mice). b C. albicans fungal burdens (CFU per g of tissue) in organs (n = 3) 1, 24, 48 and 72 h after intravenous infection with WT, atp16Δ/Δ, and atp16Δ/ATP16 (5 × 105 CFU per mice). c, d Representative images of periodic acid-Schiff- (PAS) stained kidney sections of mice (n = 3) 48 h after intravenous infection with WT, atp16Δ/Δ, and atp16Δ/ATP16 (5 × 105 CFU per mice) (c), and the combined inflammatory score based on renal immune cell infiltration (inflammation) and tissue destruction (n = 3) 1, 24, 48 and 72 h after intravenous infection with WT, atp16Δ/Δ, and atp16Δ/ATP16 (5 × 105 CFU per mice) (d). Arrowheads indicate fungal hyphae. Insets show higher-magnification images of the boxed areas; magnification ×10, ×400 (insets). Scale bars, 2000 µm, 50 µm (insets). e Blood urea nitrogen, creatine and alanine aminotransferase levels of mice (n = 3) 1, 24, 48 and 72 h after intravenous infection with WT, atp16Δ/Δ, and atp16Δ/ATP16 (5 × 105 CFU per mice). In c one representative experiment of three independent experiments is shown. In a, b, d and e, data are expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant; by log-rank test (a), or two-way ANOVA (b, d, e).
Fig. 1 A mutant C. albicans strain carrying a deletion of the δ subunit fails to cause lethal infection. a Survival curves of mice (n = 10) after intravenous injection with NS and infection with C. albicans WT (5 × 105 colony-forming units (CFU) per mice), atp16Δ/Δ (5 × 105 CFU per mice), atp16Δ/ATP16 (5 × 105 CFU per mice), and atp16Δ/Δ (5 × 106 CFU per mice). b C. albicans fungal burdens (CFU per g of tissue) in organs (n = 3) 1, 24, 48 and 72 h after intravenous infection with WT, atp16Δ/Δ, and atp16Δ/ATP16 (5 × 105 CFU per mice). c, d Representative images of periodic acid-Schiff- (PAS) stained kidney sections of mice (n = 3) 48 h after intravenous infection with WT, atp16Δ/Δ, and atp16Δ/ATP16 (5 × 105 CFU per mice) (c), and the combined inflammatory score based on renal immune cell infiltration (inflammation) and tissue destruction (n = 3) 1, 24, 48 and 72 h after intravenous infection with WT, atp16Δ/Δ, and atp16Δ/ATP16 (5 × 105 CFU per mice) (d). Arrowheads indicate fungal hyphae. Insets show higher-magnification images of the boxed areas; magnification ×10, ×400 (insets). Scale bars, 2000 µm, 50 µm (insets). e Blood urea nitrogen, creatine and alanine aminotransferase levels of mice (n = 3) 1, 24, 48 and 72 h after intravenous infection with WT, atp16Δ/Δ, and atp16Δ/ATP16 (5 × 105 CFU per mice). In c one representative experiment of three independent experiments is shown. In a, b, d and e, data are expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant; by log-rank test (a), or two-way ANOVA (b, d, e).CC BY · PubMed Central
Fig. 2 Deletion of the δ subunit abrogates lethal C. albicans infection as monitored by MicroPET. a CT, PET, and fused PET/CT images of NS-treated mice (n = 3) and WT-, atp16Δ/Δ-, and atp16Δ/ATP16-infected mice (n = 3) imaged with [18F]FDG (24, 48 and 72 h after infection). b Quantification of the in vivo PET signal intensity of NS-treated mice (n = 3) and WT-, atp16Δ/Δ-, and atp16Δ/ATP16-infected mice (n = 3) (24, 48 and 72 h after infection). c Normalization of the ratios of %ID/g in kidneys to those in the left thigh muscle (24, 48 and 72 h after infection). d The ex vivo biodistribution of [18F]FDG in the major organs of NS-treated mice (n = 3) and WT-, atp16Δ/Δ-, and atp16Δ/ATP16-infected mice (n = 3) injected with [18F]FDG (72 h after infection), as assessed with γ counter. Kidney l and Kidney r represent the left kidney and right kidney, respectively. In a one representative experiment of three independent experiments is shown. In b, c and d, data are expressed as the mean ± SD. *P < 0.05, ***P < 0.001; ns, not significant; by two-way ANOVA (b, c), or one-way ANOVA (d).
Fig. 2 Deletion of the δ subunit abrogates lethal C. albicans infection as monitored by MicroPET. a CT, PET, and fused PET/CT images of NS-treated mice (n = 3) and WT-, atp16Δ/Δ-, and atp16Δ/ATP16-infected mice (n = 3) imaged with [18F]FDG (24, 48 and 72 h after infection). b Quantification of the in vivo PET signal intensity of NS-treated mice (n = 3) and WT-, atp16Δ/Δ-, and atp16Δ/ATP16-infected mice (n = 3) (24, 48 and 72 h after infection). c Normalization of the ratios of %ID/g in kidneys to those in the left thigh muscle (24, 48 and 72 h after infection). d The ex vivo biodistribution of [18F]FDG in the major organs of NS-treated mice (n = 3) and WT-, atp16Δ/Δ-, and atp16Δ/ATP16-infected mice (n = 3) injected with [18F]FDG (72 h after infection), as assessed with γ counter. Kidney l and Kidney r represent the left kidney and right kidney, respectively. In a one representative experiment of three independent experiments is shown. In b, c and d, data are expressed as the mean ± SD. *P < 0.05, ***P < 0.001; ns, not significant; by two-way ANOVA (b, c), or one-way ANOVA (d).CC BY · PubMed Central
Fig. 3 ATP synthesis in C. albicans lacking the δ subunit. a Intracellular ATP concentrations in WT, atp16Δ/Δ and atp16Δ/ATP16 cultured in YNB + 2% glucose medium for 12 h were measured by using targeted metabolomics analysis. b The intracellular ATP content in WT, atp16Δ/Δ and atp16Δ/ATP16 (2 × 106 CFU) cultured in YPD medium for 12 h was measured by using luciferase/luciferin analysis. c, d Oxygen consumption rate (OCR) in WT, atp16Δ/Δ and atp16Δ/ATP16 in response to dicyclohexylcarbodiimide (DCCD) (100 μM), Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) (2 μM) and rotenone (Rot)/antimycin A (AA) (0.5 μM) were measured by a Seahorse XFe96 analyser (c) and bioenergetic parameters (basal respiration and OXPHOS ATP synthesis) were calculated (d). e ROS production in WT, atp16Δ/Δ and atp16Δ/ATP16 were measured by a fluorometric assay. The ratios of the fluorescence intensities of the ROS-sensitive dyes were normalized to those in WT. f Mitochondrial membrane potential (ΔΨm) in WT, atp16Δ/Δ and atp16Δ/ATP16 were measured by a fluorometric assay and the red/green mean fluorescent intensity ratio was calculated. g The expression levels of proteins involved in OXPHOS were assessed by proteomics analysis. The subunits of complex I, complex II, complex III, complex IV, F1Fo-ATP synthase and others in atp16Δ/Δ were markedly downregulated compared with those in WT, fold change >1.5 (p < 0.05). The three columns for each strain represent three experiments were performed with 3 biological replicates. h F1Fo-ATPase activity in WT, atp16Δ/Δ and atp16Δ/ATP16, were measured by an EnzChek Phosphate Assay Kit. i Glycolytic rate in WT, atp16Δ/Δ and atp16Δ/ATP16. j, k, Extracellular acidification rate (ECAR) in WT, atp16Δ/Δ and atp16Δ/ATP16 in response to the glucose (10 mM), Rot/AA (0.5 μM) and 2-DG (50 mM) were measured by Seahorse XFe96 analyser (j) and bioenergetic parameters (glycolysis) were calculated (k). l Intracellular ATP content in WT, atp16Δ/Δ and atp16Δ/ATP16 (2 × 105 CFU) in the absence (−) or presence (+) of the glycolysis inhibitor 2-DG (50 mM) after cultured in YNB + 0.2% glucose medium at 30 °C for 12 h. m Glycolytic metabolites concentrations in WT, atp16Δ/Δ and atp16Δ/ATP16 were measured by targeted metabolomics analysis. n, o, p The activities of the rate-limiting enzymes of glycolysis, Hk2 (n), Pfk1 (o), and Pyk1 (p), in WT, atp16Δ/Δ and atp16Δ/ATP16. q, r G6PD activity (q) and NADPH level (r) of the PPP pathway in WT, atp16Δ/Δ and atp16Δ/ATP16. In a, m six independent experiments were shown. In b–f, h–l, and n–r three independent experiments are shown. In a–f and h–r data were expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant; by two-tailed unpaired Student’s t-test (a, b, d–i, k, m–r), or two-way ANOVA (l).
Fig. 3 ATP synthesis in C. albicans lacking the δ subunit. a Intracellular ATP concentrations in WT, atp16Δ/Δ and atp16Δ/ATP16 cultured in YNB + 2% glucose medium for 12 h were measured by using targeted metabolomics analysis. b The intracellular ATP content in WT, atp16Δ/Δ and atp16Δ/ATP16 (2 × 106 CFU) cultured in YPD medium for 12 h was measured by using luciferase/luciferin analysis. c, d Oxygen consumption rate (OCR) in WT, atp16Δ/Δ and atp16Δ/ATP16 in response to dicyclohexylcarbodiimide (DCCD) (100 μM), Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) (2 μM) and rotenone (Rot)/antimycin A (AA) (0.5 μM) were measured by a Seahorse XFe96 analyser (c) and bioenergetic parameters (basal respiration and OXPHOS ATP synthesis) were calculated (d). e ROS production in WT, atp16Δ/Δ and atp16Δ/ATP16 were measured by a fluorometric assay. The ratios of the fluorescence intensities of the ROS-sensitive dyes were normalized to those in WT. f Mitochondrial membrane potential (ΔΨm) in WT, atp16Δ/Δ and atp16Δ/ATP16 were measured by a fluorometric assay and the red/green mean fluorescent intensity ratio was calculated. g The expression levels of proteins involved in OXPHOS were assessed by proteomics analysis. The subunits of complex I, complex II, complex III, complex IV, F1Fo-ATP synthase and others in atp16Δ/Δ were markedly downregulated compared with those in WT, fold change >1.5 (p < 0.05). The three columns for each strain represent three experiments were performed with 3 biological replicates. h F1Fo-ATPase activity in WT, atp16Δ/Δ and atp16Δ/ATP16, were measured by an EnzChek Phosphate Assay Kit. i Glycolytic rate in WT, atp16Δ/Δ and atp16Δ/ATP16. j, k, Extracellular acidification rate (ECAR) in WT, atp16Δ/Δ and atp16Δ/ATP16 in response to the glucose (10 mM), Rot/AA (0.5 μM) and 2-DG (50 mM) were measured by Seahorse XFe96 analyser (j) and bioenergetic parameters (glycolysis) were calculated (k). l Intracellular ATP content in WT, atp16Δ/Δ and atp16Δ/ATP16 (2 × 105 CFU) in the absence (−) or presence (+) of the glycolysis inhibitor 2-DG (50 mM) after cultured in YNB + 0.2% glucose medium at 30 °C for 12 h. m Glycolytic metabolites concentrations in WT, atp16Δ/Δ and atp16Δ/ATP16 were measured by targeted metabolomics analysis. n, o, p The activities of the rate-limiting enzymes of glycolysis, Hk2 (n), Pfk1 (o), and Pyk1 (p), in WT, atp16Δ/Δ and atp16Δ/ATP16. q, r G6PD activity (q) and NADPH level (r) of the PPP pathway in WT, atp16Δ/Δ and atp16Δ/ATP16. In a, m six independent experiments were shown. In b–f, h–l, and n–r three independent experiments are shown. In a–f and h–r data were expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant; by two-tailed unpaired Student’s t-test (a, b, d–i, k, m–r), or two-way ANOVA (l).CC BY · PubMed Central
Fig. 4 Deletion of the δ subunit causes defective virulence. a–d Hyphae formation of WT, atp16Δ/Δ and atp16Δ/ATP16 were induced in YPD, 10% FBS, Spider, Lee’s liquid (2 h) (a) and solid (7 d) (d) media at 37 °C. In a magnification ×400. Scale bar is 50 µM. In d scale bar is 1 cm. The percentage of hyphal cells (b) and the length of hyphae (c) were calculated from at least 100 and 20 cells in each group, respectively. e RAW264.7 macrophages preloaded with MitoTracker Deep Red FM (red) were cocultured with FITC-stained WT, atp16Δ/Δ and atp16Δ/ATP16 cells (green) at a 1:1 ratio in serum-supplemented DMEM and imaged after 3 h by confocal microscopy in the Ex644/Em655 (red), Ex488/Em525 (green) and DIC channels. Magnification ×630. Scale bar is 20 µM. f The C. albicans survival rates of WT, atp16Δ/Δ and atp16Δ/ATP16 cells by the cocultured with RAW264.7 macrophages within 48 h were determined by the end point dilution assay at each time point. g Macrophage cytotoxicity caused by WT, atp16Δ/Δ and atp16Δ/ATP16 were determined by the release of LDH. h Adhesion of WT, atp16Δ/Δ and atp16Δ/ATP16 cells to the plastic plate bottom after 24 h of shaking incubation at 37 °C. i, j Biofilm formation of WT, atp16Δ/Δ and atp16Δ/ATP16 after 6 h at 37 °C were observed by confocal microscopy in the Ex543/Em557 channel (i), and their metabolic activity was determined by XTT assay (j). Magnification ×630. Scale bar is 20 µM. k The mRNA expression levels of the virulence-related genes of WT, atp16Δ/Δ and atp16Δ/ATP16 cultured in Spider medium plus 0.2% glucose for 6 h as assessed by RT-qPCR. In a, d, e, h and i one representative experiment out of three independent experiments is shown. In f, g, j and k three independent experiments are shown. In b, c, f, g, j and k data expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant; by two-tailed unpaired Student’s t-test (b, c, j, k) and two-way ANOVA (f, g).
Fig. 4 Deletion of the δ subunit causes defective virulence. a–d Hyphae formation of WT, atp16Δ/Δ and atp16Δ/ATP16 were induced in YPD, 10% FBS, Spider, Lee’s liquid (2 h) (a) and solid (7 d) (d) media at 37 °C. In a magnification ×400. Scale bar is 50 µM. In d scale bar is 1 cm. The percentage of hyphal cells (b) and the length of hyphae (c) were calculated from at least 100 and 20 cells in each group, respectively. e RAW264.7 macrophages preloaded with MitoTracker Deep Red FM (red) were cocultured with FITC-stained WT, atp16Δ/Δ and atp16Δ/ATP16 cells (green) at a 1:1 ratio in serum-supplemented DMEM and imaged after 3 h by confocal microscopy in the Ex644/Em655 (red), Ex488/Em525 (green) and DIC channels. Magnification ×630. Scale bar is 20 µM. f The C. albicans survival rates of WT, atp16Δ/Δ and atp16Δ/ATP16 cells by the cocultured with RAW264.7 macrophages within 48 h were determined by the end point dilution assay at each time point. g Macrophage cytotoxicity caused by WT, atp16Δ/Δ and atp16Δ/ATP16 were determined by the release of LDH. h Adhesion of WT, atp16Δ/Δ and atp16Δ/ATP16 cells to the plastic plate bottom after 24 h of shaking incubation at 37 °C. i, j Biofilm formation of WT, atp16Δ/Δ and atp16Δ/ATP16 after 6 h at 37 °C were observed by confocal microscopy in the Ex543/Em557 channel (i), and their metabolic activity was determined by XTT assay (j). Magnification ×630. Scale bar is 20 µM. k The mRNA expression levels of the virulence-related genes of WT, atp16Δ/Δ and atp16Δ/ATP16 cultured in Spider medium plus 0.2% glucose for 6 h as assessed by RT-qPCR. In a, d, e, h and i one representative experiment out of three independent experiments is shown. In f, g, j and k three independent experiments are shown. In b, c, f, g, j and k data expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant; by two-tailed unpaired Student’s t-test (b, c, j, k) and two-way ANOVA (f, g).CC BY · PubMed Central
Fig. 5 Deletion of the δ subunit blocks the FBP-mediated cAMP-PKA pathway. a Relative mRNA expression levels of the genes involved in the cAMP-PKA pathway in WT, atp16Δ/Δ and atp16Δ/ATP16 were assessed by RT-qPCR. b PKA activities in WT, atp16Δ/Δ and atp16Δ/ATP16 were assayed with colorimetric quantitative determination kits. c Intracellular cAMP concentrations in WT, atp16Δ/Δ and atp16Δ/ATP16 (2 × 104 CFU) were assayed with a cAMP-Glo™ Assay kit. d, e Hyphae formation of WT, atp16Δ/Δ and atp16Δ/ATP16 in the presence of exogenous cAMP (0, 1, 5, 10 mM) (d) or 3-isobutyl-1-methylxanthine (IBMX) (0, 0.01, 0.05, 0.1 mM) (e) in Spider medium after incubation at 37 °C for 3.5 h. f Intracellular FBP concentration per mg protein in WT, atp16Δ/Δ and atp16Δ/ATP16. g Hyphae formation of WT and atp16Δ/Δ in the presence of exogenous FBP (0, 5, 10, 20 mM) in Spider medium after incubation at 37 °C for 3.5 h. h Intracellular cAMP concentrations of WT, atp16Δ/Δ and atp16Δ/ATP16 (2 × 104 CFU) in the absence (−) or presence (+) of FBP (20 μM). i GTP-Ras1 levels before and 3 min after the addition of different concentrations of FBP (0, 5, 20 mM) to permeabilized spheroplasts of atp16Δ/Δ. GAPDH was used as a loading control. j Intracellular cAMP concentrations of WT (SN250) and ras1Δ/Δ (2 × 104 CFU) in the absence (−) or presence (+) of exogenous FBP (20 μM). Magnification ×400. Scale bar is 50 µM. In a, b, c, f, h and j data are expressed as the mean ± SD of three independent experiments. In d, e, g and i one representative experiment out of three independent experiments is shown. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant; by two-tailed unpaired Student’s t-test (a, b, c, f), or two-way ANOVA (h, j).
Fig. 5 Deletion of the δ subunit blocks the FBP-mediated cAMP-PKA pathway. a Relative mRNA expression levels of the genes involved in the cAMP-PKA pathway in WT, atp16Δ/Δ and atp16Δ/ATP16 were assessed by RT-qPCR. b PKA activities in WT, atp16Δ/Δ and atp16Δ/ATP16 were assayed with colorimetric quantitative determination kits. c Intracellular cAMP concentrations in WT, atp16Δ/Δ and atp16Δ/ATP16 (2 × 104 CFU) were assayed with a cAMP-Glo™ Assay kit. d, e Hyphae formation of WT, atp16Δ/Δ and atp16Δ/ATP16 in the presence of exogenous cAMP (0, 1, 5, 10 mM) (d) or 3-isobutyl-1-methylxanthine (IBMX) (0, 0.01, 0.05, 0.1 mM) (e) in Spider medium after incubation at 37 °C for 3.5 h. f Intracellular FBP concentration per mg protein in WT, atp16Δ/Δ and atp16Δ/ATP16. g Hyphae formation of WT and atp16Δ/Δ in the presence of exogenous FBP (0, 5, 10, 20 mM) in Spider medium after incubation at 37 °C for 3.5 h. h Intracellular cAMP concentrations of WT, atp16Δ/Δ and atp16Δ/ATP16 (2 × 104 CFU) in the absence (−) or presence (+) of FBP (20 μM). i GTP-Ras1 levels before and 3 min after the addition of different concentrations of FBP (0, 5, 20 mM) to permeabilized spheroplasts of atp16Δ/Δ. GAPDH was used as a loading control. j Intracellular cAMP concentrations of WT (SN250) and ras1Δ/Δ (2 × 104 CFU) in the absence (−) or presence (+) of exogenous FBP (20 μM). Magnification ×400. Scale bar is 50 µM. In a, b, c, f, h and j data are expressed as the mean ± SD of three independent experiments. In d, e, g and i one representative experiment out of three independent experiments is shown. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant; by two-tailed unpaired Student’s t-test (a, b, c, f), or two-way ANOVA (h, j).CC BY · PubMed Central
Fig. 6 Deletion of the δ subunit attenuates Pfk1 activity via dephosphorylation to perturb its conformation. a Pfk1 activity of WT, atp16Δ/Δ and atp16Δ/ATP16 in the absence (−) or presence (+) of alkaline phosphatase (2.5 U). b Pfk1 activity of WT, atp16Δ/Δ and atp16Δ/ATP16 in the absence (−) or presence (+) of phosphatase inhibitor (5 μl). c Pfk1 phosphorylation levels were determined by immunoblotting after the enzymes purified by Affi-gel blue and ion-exchange chromatography from WT, atp16Δ/Δ and atp16Δ/ATP16 with anti-phosphorylated tyrosine (p-Tyr) antibody, anti-phosphorylated threonine (p-Thr) antibody and anti-phosphorylated serine (p-Ser) antibody, respectively. d Quantification of Pfk1 p-Tyr, p-Thr and p-Ser phosphorylation in WT, atp16Δ/Δ and atp16Δ/ATP16 by densitometry. e The activity of Pfk1 purified by polymer-bound Cibacron Blue F3G-A and eluted with different concentrations of ATP. In a, b, d and e data are shown as the mean ± SD of three independent experiments. In c one representative experiment out of three independent experiments is shown. ***P < 0.001; ns, not significant; by two-way ANOVA (a, b and e), or two-tailed unpaired Student’s t-test (d).
Fig. 6 Deletion of the δ subunit attenuates Pfk1 activity via dephosphorylation to perturb its conformation. a Pfk1 activity of WT, atp16Δ/Δ and atp16Δ/ATP16 in the absence (−) or presence (+) of alkaline phosphatase (2.5 U). b Pfk1 activity of WT, atp16Δ/Δ and atp16Δ/ATP16 in the absence (−) or presence (+) of phosphatase inhibitor (5 μl). c Pfk1 phosphorylation levels were determined by immunoblotting after the enzymes purified by Affi-gel blue and ion-exchange chromatography from WT, atp16Δ/Δ and atp16Δ/ATP16 with anti-phosphorylated tyrosine (p-Tyr) antibody, anti-phosphorylated threonine (p-Thr) antibody and anti-phosphorylated serine (p-Ser) antibody, respectively. d Quantification of Pfk1 p-Tyr, p-Thr and p-Ser phosphorylation in WT, atp16Δ/Δ and atp16Δ/ATP16 by densitometry. e The activity of Pfk1 purified by polymer-bound Cibacron Blue F3G-A and eluted with different concentrations of ATP. In a, b, d and e data are shown as the mean ± SD of three independent experiments. In c one representative experiment out of three independent experiments is shown. ***P < 0.001; ns, not significant; by two-way ANOVA (a, b and e), or two-tailed unpaired Student’s t-test (d).CC BY · PubMed Central
Fig. 7 Identification of a compound potentially targeting the δ subunit that inhibits C. albicans pathogenicity. a Flowchart of the structure-based virtual screening strategy. A total of 256,270 compounds from the SPECS database were docked into the binding pocket (red grid) of the C. albicans δ subunit generated by homology modelling (PDB ID: 6CP3). After rigid and flexible docking and ranking, 20 compounds were selected to perform antifungal assays with WT, atp16Δ/Δ and atp16Δ/ATP16 and cytotoxicity assays in liver (LO-2) and kidney (HK-2) cells. b The chemical structure of compound S1. c Growth of WT, atp16Δ/Δ and atp16Δ/ATP16 in the absence (−) or presence (+) of S1 (10 μM) over time determined by cell density (OD600) in YPD (left) and YPS (right) media. d Hyphae formation of WT, atp16Δ/Δ and atp16Δ/ATP16 in the absence (−) or presence (+) of S1 (10 μM) in Spider medium after 3 h of incubation at 37 °C. Magnification ×200; scale bars 100 µm. e Intracellular ATP content in WT, atp16Δ/Δ and atp16Δ/ATP16 (2 × 106 CFU) in the absence (control) or presence of S1 (10 µM) and oligomycin (10 µM) after cultured in YPS medium at 30 °C for 12 h. f The binding mode of the S1 and δ subunit. The N atom of S1 formed a hydrogen bond with the hydroxyl oxygen atom of the amino acid residue Ser94. g Survival curves of mice (n = 8) after intravenous infection with WT (2 × 105 CFU per mice) without or with 7 days of S1 treatment (50 mg/kg and 100 mg/kg) and fluconazole (FLC) treatment (10 mg/kg) by oral gavage. h C. albicans fungal burdens (CFU per g tissue) in kidneys, brains, livers, spleens (n = 4) 8 days after intravenous infection with WT (2 × 105 CFU per mice) with 7 days of S1 treatment (50 mg/kg and 100 mg/kg) and FLC treatment (10 mg/kg) by oral gavage. i, j Representative images of PAS-stained kidney sections of WT (2 × 105 CFU per mice) infected mice (n = 3) with 7 days of S1 treatment (50 mg/kg and 100 mg/kg) and FLC treatment (10 mg/kg) by oral gavage (j), and the combined inflammatory score based on renal immune cell infiltration (inflammation) and tissue destruction (i). In c, e three independent experiments are shown. In d, j one representative experiment of three independent experiments is shown. In c, e, g, h and i data are shown as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001; by two-way ANOVA (c), log-rank test (g) or two-tailed unpaired Student’s t-test (e, h and i). In j Arrowheads indicate fungal hyphae. Insets show higher-magnification images of boxed areas; magnification ×10, ×400 (insets); scale bars, 2000 µm, 50 µm (insets).
Fig. 7 Identification of a compound potentially targeting the δ subunit that inhibits C. albicans pathogenicity. a Flowchart of the structure-based virtual screening strategy. A total of 256,270 compounds from the SPECS database were docked into the binding pocket (red grid) of the C. albicans δ subunit generated by homology modelling (PDB ID: 6CP3). After rigid and flexible docking and ranking, 20 compounds were selected to perform antifungal assays with WT, atp16Δ/Δ and atp16Δ/ATP16 and cytotoxicity assays in liver (LO-2) and kidney (HK-2) cells. b The chemical structure of compound S1. c Growth of WT, atp16Δ/Δ and atp16Δ/ATP16 in the absence (−) or presence (+) of S1 (10 μM) over time determined by cell density (OD600) in YPD (left) and YPS (right) media. d Hyphae formation of WT, atp16Δ/Δ and atp16Δ/ATP16 in the absence (−) or presence (+) of S1 (10 μM) in Spider medium after 3 h of incubation at 37 °C. Magnification ×200; scale bars 100 µm. e Intracellular ATP content in WT, atp16Δ/Δ and atp16Δ/ATP16 (2 × 106 CFU) in the absence (control) or presence of S1 (10 µM) and oligomycin (10 µM) after cultured in YPS medium at 30 °C for 12 h. f The binding mode of the S1 and δ subunit. The N atom of S1 formed a hydrogen bond with the hydroxyl oxygen atom of the amino acid residue Ser94. g Survival curves of mice (n = 8) after intravenous infection with WT (2 × 105 CFU per mice) without or with 7 days of S1 treatment (50 mg/kg and 100 mg/kg) and fluconazole (FLC) treatment (10 mg/kg) by oral gavage. h C. albicans fungal burdens (CFU per g tissue) in kidneys, brains, livers, spleens (n = 4) 8 days after intravenous infection with WT (2 × 105 CFU per mice) with 7 days of S1 treatment (50 mg/kg and 100 mg/kg) and FLC treatment (10 mg/kg) by oral gavage. i, j Representative images of PAS-stained kidney sections of WT (2 × 105 CFU per mice) infected mice (n = 3) with 7 days of S1 treatment (50 mg/kg and 100 mg/kg) and FLC treatment (10 mg/kg) by oral gavage (j), and the combined inflammatory score based on renal immune cell infiltration (inflammation) and tissue destruction (i). In c, e three independent experiments are shown. In d, j one representative experiment of three independent experiments is shown. In c, e, g, h and i data are shown as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001; by two-way ANOVA (c), log-rank test (g) or two-tailed unpaired Student’s t-test (e, h and i). In j Arrowheads indicate fungal hyphae. Insets show higher-magnification images of boxed areas; magnification ×10, ×400 (insets); scale bars, 2000 µm, 50 µm (insets).CC BY · PubMed Central

Verification

Claims the paper makes

14 Valid · 0 Not valid · 14 Not checked · 127 Own results and interpretations

97 more claims

Create a free account to see all 155 claims and to verify the 5 references still open.

See all claims — free account
  • Probably not a substantial claim. 29
  • It may state two separate claims as one. 31
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 56 references

Cited by

See all 21

Metadata

Authors
Li, S., Zhao, Y., Zhang, Y., Zhang, Y., Zhang, Z., Tang, C., Weng, L., Chen, X., Zhang, G., & Zhang, H.
Affiliations
  • Jinan University (CN)
  • Third Affiliated Hospital of Sun Yat-sen University (CN)
Corresponding author
  • Zhang, Gehua
  • Zhang, Hong
Venue
Nature Communications
Published
2021-10-15
Volume
12
Issue
1
Pages
6041-6041
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3205059665
Cited by
21
References
56
Citations by year
2026: 4 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 2
FWCI
0.87
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • China Postdoctoral Science Foundation (2019M653291)
  • National Natural Science Foundation of China (81971913, 81903675, 81471995)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
Keywords
F1FO-ATP synthase, delta subunit, Candida albicans, systemic candidiasis, fungal pathogenicity, oxidative phosphorylation, glycolysis, phosphofructokinase, cAMP/PKA signaling, Ras1, virulence factors, antifungal drug targets, virtual screening, mouse infection model
MeSH terms
RAW 264.7 Cells, Adenosine Triphosphate, Animals, Antifungal Agents, Candida albicans, Candidiasis, Fungal Proteins, Glycolysis, Oxidative Phosphorylation, Virulence, Down-Regulation, Gene Expression Regulation, Fungal, Biofilms, Mitochondrial Proton-Translocating ATPases, Virulence Factors, Proteomics, Mice, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The δ subunit of F1Fo-ATP synthase is required for pathogenicity of Candida albicans. https://app.cochat.ai/papers/10.1038/s41467-021-26313-9
The paper
Li, S., Zhao, Y., Zhang, Y., Zhang, Y., Zhang, Z., Tang, C., Weng, L., Chen, X., Zhang, G., & Zhang, H. (2021). The δ subunit of F1Fo-ATP synthase is required for pathogenicity of Candida albicans. Nature Communications. https://doi.org/10.1038/s41467-021-26313-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.